UBS analyst Alex Ye upgrades FinVolution Gr (NYSE:FINV) from Neutral to Buy.
Sanofi Earns Price Target Cut After Stopping Breast Cancer Drug Trial
Sanofi SA (NASDAQ:SNY) discontinued the development of its oral SERD amcenestrant following a negative interim analysis of the AMEERA-5…